MW
GILD icon

MBL Wealth’s Gilead Sciences GILD Stock Holding History

MBL Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
3,094
-82
-3% -$10.8K 0.03% 241
2026
Q1 		$443K Buy
3,176
+5
+0.2% +$700 0.03% 217
2025
Q4 		$389K Buy
+3,171
New +$385K 0.03% 206

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MBL Wealth's GILD Position: Q2 2026 in Review

MBL Wealth reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $10.8K and leaving 3,094 shares worth $391K. The position accounts for 0.03% of the portfolio, ranked #241.

MBL Wealth first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $443K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MBL Wealth held 3,094 shares of Gilead Sciences worth $391K as of Q2 2026.
  • MBL Wealth sold 82 Gilead Sciences shares in Q2 2026, an estimated $10.8K.
  • Gilead Sciences made up 0.03% of MBL Wealth's portfolio in Q2 2026, its #241 holding.
  • MBL Wealth first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • MBL Wealth's Gilead Sciences position peaked at $443K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.